- Home
- TK vs MYGN Comparison
TK vs MYGN Comparison
Compare TK & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TK
- MYGN
- Stock Information
- Founded
- TK 1973
- MYGN 1991
- Country
- TK Bermuda
- MYGN United States
- Employees
- TK N/A
- MYGN N/A
- Industry
- TK Marine Transportation
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- TK Consumer Discretionary
- MYGN Health Care
- Exchange
- TK Nasdaq
- MYGN Nasdaq
- Market Cap
- TK 679.6M
- MYGN 756.5M
- IPO Year
- TK 1995
- MYGN 1995
- Fundamental
- Price
- TK $9.60
- MYGN $6.73
- Analyst Decision
- TK
- MYGN Hold
- Analyst Count
- TK 0
- MYGN 14
- Target Price
- TK N/A
- MYGN $13.23
- AVG Volume (30 Days)
- TK 598.2K
- MYGN 1.0M
- Earning Date
- TK 10-29-2025
- MYGN 11-03-2025
- Dividend Yield
- TK 21.21%
- MYGN N/A
- EPS Growth
- TK N/A
- MYGN N/A
- EPS
- TK 0.88
- MYGN N/A
- Revenue
- TK $992,518,000.00
- MYGN $825,300,000.00
- Revenue This Year
- TK N/A
- MYGN $0.06
- Revenue Next Year
- TK N/A
- MYGN $5.68
- P/E Ratio
- TK $10.92
- MYGN N/A
- Revenue Growth
- TK N/A
- MYGN 0.21
- 52 Week Low
- TK $5.65
- MYGN $3.76
- 52 Week High
- TK $9.65
- MYGN $19.60
- Technical
- Relative Strength Index (RSI)
- TK 67.91
- MYGN 36.42
- Support Level
- TK $9.30
- MYGN $6.22
- Resistance Level
- TK $9.65
- MYGN $8.38
- Average True Range (ATR)
- TK 0.29
- MYGN 0.44
- MACD
- TK 0.08
- MYGN -0.17
- Stochastic Oscillator
- TK 95.93
- MYGN 22.54
About TK Teekay Corporation
Teekay Corp Ltd provides international crude oil marine transportation and other marine services. It also offers offshore oil production, storage, and offloading services, under long-term, fixed-rate contracts. The company has two primary lines of business: Marine services and tankers. It manages these businesses for the benefit of all stakeholders. The company serves energy and utility companies, oil traders, large oil and LNG consumers, petroleum product producers, government agencies, and various other entities that depend upon marine transportation.
About MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.